4th Quarter - Report

GILBERT'S LLP for MYLAN LABORATORIES INC

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
$90,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
4th Quarter - Report (this page) Feb 9, 2009 $90,000 Replaced
4th Quarter - Amendment Oct 23, 2009 $90,000 Yes

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Reform to legislation and regulations affecting pharmaceutical drug approval and marketing

LobbyistCovered position, as disclosed
NAWEL BAILEY —
TIM GILBERT —
NATHANIEL BRANDON LIPKUS —

Contacted: Federal Trade Commission (FTC); SENATE; HOUSE OF REPRESENTATIVES

Consumer Issues/Safety/Products CSP

Reform to legislation and regulations affecting pharmaceutical drug approval and marketing

LobbyistCovered position, as disclosed
NAWEL BAILEY —
TIM GILBERT —
NATHANIEL BRANDON LIPKUS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Federal Trade Commission (FTC)

Pharmacy PHA

Reform to legislation and regulations affecting pharmaceutical drug approval and marketing

LobbyistCovered position, as disclosed
NAWEL BAILEY —
TIM GILBERT —
NATHANIEL BRANDON LIPKUS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Federal Trade Commission (FTC)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.